Skip to content
Clinical Trials – home
Therapeutic area

Psychiatric disorders – page 17

  • 546 clinical trials
  • 252 recruiting
  • 147 conditions
  • 26 countries

Conditions in this area

147 conditions with trials, the busiest first

Clinical trials in Psychiatric disorders

546 trials across Europe, recruiting first

Type of trial
Recruitment status
Quick filters

546 clinical trials

Study on Dexamfetamine for Adults with Amphetamine and Opioid Dependence Undergoing Opioid Treatment

Investigational
Countries:NorwayNorway
  • Participants:18–64 years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:Helse Bergen HF

Study Comparing Lithium and Lamotrigine for Mood Stabilization in Patients with Bipolar Disorder Type II

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Lamotrigine
  • Sponsor:Frederiksberg Hospital

Study on Fluasterone for Managing High Blood Sugar in Adults with Cushing's Syndrome

Investigational
Countries:GreeceGreece
  • Participants:18–64 years · 65+ years
  • Substances:Fluasterone
  • Sponsor:Sterotherapeutics LLC

Study on Nitrous Oxide and Oxygen for Treating Depression in Nursing Home Residents with Neurocognitive Disorders

Registered drugNo placebo
Countries:FranceFrance
  • Participants:65+ years
  • Substances:Nitrogen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Study on Treating Anemia After Cesarean with Ferric Carboxymaltose or Oral Iron in Women with Moderate Iron Deficiency Anemia

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Ascorbic Acid
  • Sponsor:Assistance Publique Hopitaux De Paris

Depression

Recruiting

Study on Ketamine and CBASP for Treating Chronic Depression in Adults

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Sodium Chloride
  • Sponsor:Universitaetsklinikum Tuebingen AöR

Study on MDMA-Assisted Therapy for Patients with Treatment-Resistant PTSD

InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Midomafetamine Hydrochloride
  • Sponsor:ARQ National Psychotrauma Centrum

Study on AVB-101 for Patients with Frontotemporal Dementia with Progranulin Mutations

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Avb-101
  • Sponsor:Aviadobio Limited

Study on Mifepristone for Patients with Treatment-Resistant Post-Traumatic Stress Disorder (PTSD)

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:Mifepristone
  • Sponsor:Amsterdam UMC Stichting

Study on Reducing Suicidal Thoughts in Emergency Patients Using Nitrous Oxide and Oxygen Therapy

Registered drugNo placebo
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Nitrogen
  • Sponsor:Centre Hospitalier Regional Universitaire De Tours

Study on Buprenorphine for Treating Severe Suicidal Thoughts in Patients with Major Depression

Registered drug
Countries:FranceFrance
  • Participants:18–64 years
  • Substances:Buprenorphine
  • Sponsor:Centre Hospitalier Universitaire De Nimes

Psychotic disorder+1

Recruiting

Study on Improving Social Skills in Schizophrenia Using Oxytocin or Placebo as an Add-On Treatment for Patients with Schizophrenia Spectrum Disorders

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Oxytocin
  • Sponsor:Zentralinstitut Fuer Seelische Gesundheit

Substances studied in this area

The therapies tested most often in Psychiatric disorders trials.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.